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Abstract: 
Staphylococcus aureus infections acquired in hospitals now cause more deaths per annum in the 
US than does HIV/AIDS. Perhaps even more alarming is the rise in community associated 
methicillin-resistant S. aureus (CA-MRSA) infections, which have spread out of hospital settings 
and are infecting otherwise healthy individuals. The mechanism of enhanced pathogenesis in 
CA-MRSA remains unclear, but it has been postulated that high activity in the agr quorum-
sensing system could be a contributing factor. The purpose of this study was to develop a 
quantitative method for analysis of autoinducing peptide I (AIP-I), the activating signal for 
the agr system in S. aureus. An effective method was developed using ultrahigh performance 
liquid chromatography (UHPLC) coupled to electrospray ionization mass spectrometry with an 
LTQ Orbitrap mass spectrometer. Relying on the exceptional resolving power and mass accuracy 
of this instrument configuration, it was possible to quantify AIP-I directly from the complex 
growth media of S. aureus cultures with a limit of detection (LOD) of 0.25 μM and a linear 
dynamic range of 2.6 to 63 μM. The method was then employed to monitor time-dependent 
production of AIP-I by S. aureus cultures, and it was observed that AIP-I production reached a 
maximum and leveled off after approximately 16 h. Finally, it was determined that virulence 
of S. aureus was correlated with AIP-I production in some (but not all) strains analyzed. 
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1. Introduction 
Staphylococcus aureus as a bacterial pathogen has a major impact on the healthcare system in 
the US. According to one estimate, methicillin-resistant S. aureus (MRSA) infections caused 
over 100,000 infections and 18,000 deaths in 2005 [1]. Over the past decade, MRSA strains have 
spread to the community and are infecting otherwise healthy individuals, and these strains have 
been called community-associated MRSA (CA-MRSA) [2] and [3]. The CA-MRSA strains are 
known for being hypervirulent compared to older healthcare-associated MRSA (HA-MRSA) [4], 
and it has been proposed that the enhanced function of theagr quorum sensing system and 
production of virulence factors is in part responsible for the rise in CA-MRSA 
incidence [5], [6] and [7]. 
Quorum sensing in S. aureus is mediated by cyclic thiolactone peptides known as autoinducing 
peptides (AIPs) [8]. The extracellular concentration of AIP is sensed by a two-component system 
encoded in the accessory gene regulator (agr) locus. At a critical signal level, the cascade is 
activated, leading to the production of virulence factors that include toxins, superantigens, and 
exo-enzymes [9]. Considering that variation in agr system function has been linked to MRSA 
pathogenesis, methods to accurately detect and quantify AIPs would be very useful for studying 
virulence regulation in S. aureus. The goal of this paper was to develop a quantitative method for 
the determination of AIP type I (AIP-I) from the spent media of S. aureuscultures. AIP-I is 
produced by the outbreak USA300 strains that represent the most common lineage of CA-
MRSA [10] and [11]. 
Chait et al. previously published the only existing report of AIP detection from S. aureus culture 
medium without pre-concentration [12]. Relying on comparisons with fragmentation patterns of 
a synthetic AIP-I, they effectively employed MALDI-TOF-TOF MS for rapid identification of 
AIP-I in spent media. However, it was not possible to detect the molecular ion for AIP-I due to 
interference by media components, and the method was not quantitative. No direct LC–MS 
methods have been published for AIP quantitation, although McDowell et al. reported 
approximately ~10 μM and ~14 μM of AIP-I and its sulfoxide derivative, respectively, from S. 
aureus RN6390B. For the McDowell study, solid-phase extraction of the culture supernatant 
followed by two stages of reversed phase HPLC purification was employed. The process was 
quite time-consuming, requiring bioassays of fractions to guide the isolation process [13]. 
The presence of other interfering compounds in the growth media (as demonstrated by Kalkum 
et al. [12]) combined with the low levels of AIP-I secreted by the bacteria (as demonstrated by 
McDowell et al. [13]) complicate its quantitative analysis. The goal of these studies was to 
overcome these challenges utilizing the exceptional resolution of ultrahigh performance liquid 
chromatography (UHPLC) coupled to high resolving power mass spectrometry. We sought to 
employ these techniques to monitor the time dependent production of AIP-I by S. aureus, and to 
compare the levels of AIP-I produced by methicillin-susceptible S. aureus (MSSA), HA-MRSA 
and CA-MRSA strains [8]. 
2. Materials and methods 
2.1. Reagents, standards and organisms 
AIP-I (≥95% purity by HPLC) was obtained from AnaSpec Inc. (Fremont, CA). S. aureus strains 
were maintained in tryptic soy broth (TSB) or on tryptic soy agar (TSA) plates at 37 °C. The 
strains used for these studies were as follows: USA300 LAC [14], USA300 TCH1516 [15], 
HG001 [16], COL [17], FRI1169 [18], and four CC45 strains that included AH1886 (NRS169), 
AH1887 (NRS22), AH1888 (NRS27), AH1889 (NRS236). The CC45 strains were kindly 
provided by Dr. Barry Kreiswirth. As a control, the Δagr::TetM mutation was crossed from 
strain AH1292 [19] into RN4220 by bacteriophage 80α transduction using methods described 
previously [20]. The resulting strain, AH2492 (RN4220 Δagr::TetM), was transformed with 
either plasmid pEPSA5 [21] or pAgrD1 [22]. Plasmid pAgrD1 contains the agrBD type I genes 
in pEPSA5, and the expression of these genes in an Δagr::TetM mutant restores AIP-I 
production. Plasmid electroporation was performed as described previously [23] and 
transformants were maintained on TSA supplemented with chloramphenicol (10 μg/mL). 
2.2. UHPLC-ESI-HRMS conditions 
Samples were analyzed utilizing an LTQ Orbitrap XL mass spectrometer with electrospray 
ionization source (Thermo, San Jose, CA) coupled to an Acquity UHPLC HSS T3 (Waters, 
Milford, MA). A C18 column (Acquity BEH, 2.1 mm × 50 mm, 1.8 μm packing) was used. Flow 
rate was 0.25 mL/min, and injection volume was 3 μL. Samples were eluted at 0.25 mL/min 
using a two-step gradient from 80:20 to 40:60 water:acetonitrile (both containing 0.1% formic 
acid) from 0 to 5 min, then from 40:60 to 80:20 from 5 to 5.5 min. 
The Orbitrap was operated over a scan range of m/z 300 to 2000, with resolving power of 30,000. 
MS–MS was conducted in data dependent scanning mode, using a collision induced dissociation 
(CID) activation energy of 35%. Instrument parameters were as follows, tube lens voltage, 
100 V, source voltage, 4.50 kV, source current, 100.00 μA, and heated capillary voltage, 20 V. 
The AIP I concentration was calculated based on a calibration curve generated as area of the 
relevant selected ion peak versus concentration. A mass of 961.3794 ± 0.0048 (calcd accurate 
mass for the M+H+ion of AIP-I, ±5 ppm) was set for the selected ion chromatogram, and AIP I 
concentrations were calculated using the slope of the best-fit line of this calibration curve, as 
determined with linear regression analysis. This 5 ppm window was chosen to reduce 
interference from isobaric matrix components. 
2.3. MRSA culture 
For studies comparing AIP-I production among various MRSA strains, a single colony inoculum 
of the relevant strain (see Section 2.1) was incubated in tryptic soy broth (TSB) at 37 °C for 24 h. 
Triplicate flasks containing 1:200 sub-cultures were then incubated with shaking at 200 rpm and 
37 °C until they reached OD600 (absorbance at 600 nm) of at least 2.0 after a 20 h minimum 
growth period. This medium was then vacuum filtered through a 0.22 μm surfactant-free 
cellulose acetate (SFCA) membrane and stored at −80 °C until time of analysis by UHPLC-ESI-
HRMS. For the time course study, a 24 h culture of MRSA USA300 strain AH1263 was diluted 
1:100 in triplicate flasks containing TSB and grown with shaking for 21 h. An aliquot was 
removed from each flask every hour, the OD600 was recorded, and the culture was filter sterilized 
and analyzed using UHPLC-ESI-HRMS as described above. 
2.4. Red blood cell lysis assays 
S. aureus strains were grown in TSB to an OD600 of 2.0, spent media was collected, and filtered 
through a 0.22 μm membrane (Spin-X filters, Corning Costar). Rabbit red blood cell (RBC) lysis 
assays to assess alpha-toxin levels were performed as previously described [24]. Association 
between % lysis activity and AIP I concentration was evaluated using a Pearson correlation with 
two-sided p-value using SAS software (V. 9.3). 
3. Results and discussion 
3.1. Identification of AIP-I from spent media 
AIP-I, Tyr-Ser-Thr-c(Cys-Asp-Phe-Ile-Met), is a cyclic octapeptide with a thiolactone ring 
linked between the sulfhydryl group of the cysteine and the α-carboxyl group of the C-terminal 
methionine [25]. The major goal in this study was to develop an analytical method that would 
enable detection of AIP-I directly from S. aureusculture medium. This was achieved using 
ultrahigh performance liquid chromatography (UHPLC) coupled to high resolving power mass 
spectrometry ( Fig. 1). Peaks representing the M+H+ ion of the AIP-I peptide are evident in the 
selected ion chromatograms (961.3794 ± 0.0048) for both the spent media of CA-MRSA 
USA300 strain LAC ( Fig. 1B) and standard AIP-I ( Fig. 1C) at retention times of 3.26 min and 
3.22 min, respectively. This compound was not detected in the growth medium control (tryptic 
soy broth) ( Fig. 1A). Correct assignment of molecular formula for the AIP-I ion was confirmed 
by accurate mass measurements of both the putative AIP-I [M+H]+ ion from the spent media 
(calcd 961.3794, measured 961.3797, 0.3 ppm mass error) and the standard AIP I (calcd 
961.3794, measured 961. 3790, 0.4 ppm mass error). AIP-I with oxidized methionine was also 
detected in the supernatant (calcd 977.3743, measured 977.3747, 0.4 ppm mass error) and 
standard solution (calcd 977.3743, measured 977.3755, 1.2 ppm accuracy) at ~20% of the 
abundance of the protonated molecular ion peak for AIP (data not shown). 
 
Fig. 1. Selected ion chromatogram (m/z 961.38) for tryptic soy broth (A), cell-free culture 
supernatant for CA-MRSA USA300 strain LAC (B), and 3.47 μM standard AIP-I in broth (C). 
Both the supernatant (B) and the standard (C) solution exhibited the AIP-I peak with masses of 
961.3797 and 961.3790 (mass error 0.3 ppm) and 961.3790 (mass error −0.4 ppm) at retention 
times of 3.26 and 3.22 min, respectively. The chromatogram is normalized at 2.84 × 106 counts. 
Several compounds with the same nominal mass of AIP-I were also detected in the culture 
medium, and are observed as additional peaks at earlier retention times in the selected ion 
chromatograms (Fig. 1). Thus, the use of accurate mass measurements and MS–MS 
fragmentation patterns was essential for the correct assignment of the AIP-I for these 
experiments. The MS2 (collision induced dissociation) fragmentation spectrum using the 
[M+H]+ ion of standard AIP-I (Fig. 2A) as the precursor (m/z 961.4) was nicely aligned with the 
MS2 spectrum for the putative AIP-I from the media ( Fig. 2B). The MS2 spectrum also agreed 
with that previously published for AIP-I [12]. Finally, the MS3 spectrum obtained using the most 
abundant MS2fragment of the putative AIP-I, m/z 711.30, as precursor ( Fig. 3) matched the 
MS3 spectrum for AIP-I standard. 
 
Fig. 2. Mass spectra of MS2 fragments (with precursor ion 961.4) for AIP-I in cell-free culture 
supernatant from strain LAC (A) and 3.47 μM standard AIP-I in tryptic soy broth (B). 
 
Fig. 3. Collision induced dissociation fragmentation pattern of the 711.3 fragment of the 961.4 
precursor (MS3) for AIP-I in cell-free culture supernatant from strain LAC (A) and standard AIP-
I solution in TSB (B). 
As further confirmation of correct identification of AIP-I, experiments were performed using 
an S. aureus agrdeletion mutant (AH2492) that is unable to produce AIP-I. This strain was 
transformed with expression plasmid pEPSA5 [21]. As apparent from the chromatogram shown 
in Fig. 4A, no AIP-I was detected in the spent media from this mutant strain. When pEPSA5 
containing the agrBD genes (pAgrD1 [22]) was transformed into the agr mutant, AIP-I 
production was restored as anticipated ( Fig. 4B). The MS–MS spectrum for the putative AIP-I 
in the media from engineered producing strain matched the MS–MS spectrum for standard AIP-
I, and accurate mass measurements confirmed the molecular formula with 0.4 ppm mass 
accuracy (data now shown). 
 
Fig. 4. Selected ion chromatograms for the mass corresponding to the [M+H]+ ion of AIP I ion 
(961.2) for cell-free culture supernatant from a S. aureus agr mutant with plasmid pEPSA5 (A), 
cell free culture supernatant from a S. aureus agr mutant with plasmid pAgrD1 that produces 
AIP-I (B) and 3.47 μM standard AIP-I in TSB (C). All chromatograms were normalized to a 
signal of 9.5 × 105. 
3.2. Method validation for AIP-I quantitation 
Taking advantage of the excellent chromatographic resolution provided by the UHPLC, it was 
possible to achieve baseline resolution between the AIP-I and the interfering compounds present 
in the TSB (Fig. 1B). Notably, this method was also very rapid, requiring only a 6 min total 
UHPLC run time. The ability (relying on the high resolving power of the Orbitrap mass 
analyzer) to limit the window for the selected ion chromatogram to ±5 ppm was essential for 
quantitation, preventing signal from the interferences from being falsely assigned to the AIP I. 
Using this approach, a linear dynamic range for quantitation of AIP-I of 2.6–63 μM was 
achieved, with a limit of detection (defined as the concentration necessary to achieve signal 
3 × noise) of 0.25 μM (Table 1). Below 2.6 μM and above 63 μM, the curve deviated from 
linearity. This deviation was attributed to components of the tryptic soy broth used to culture the 
bacteria (and as the matrix for standard preparation); the linear dynamic range was expanded by 
over an order of magnitude when the standards were instead prepared in acetonitrile (data not 
shown). Nonetheless, our intention with this study was to develop a method that would be 
applicable for rapid of analysis of peptides produced by bacteria grown in rich media. Therefore, 
tryptic soy broth was used as the matrix for standard preparation in all of the subsequent studies 
to enable analysis of samples in tryptic soy broth without concerns of inaccuracies due to matrix 
suppression. Even in the tryptic soy broth medium, sufficient linearity, limit of detection, limit of 
quantitation (Table 1), precision, and accuracy (Table 2) where achieved to enable quantitation 
of AIP-I in relevant biological samples. 
Table 1. Regression parameters, detection limit, and limit of quantitation for analysis of AIP-I in 
tryptic soy broth. 
Validation parameter Result 
Correlation coefficient 0.997 
Standard error 3.78 × 106 
y-intercept −1.91 × 106 ± 2.2 × 106 
Slope of regression line 3.06 × 106 ± 6.4 × 104 
Number of data points 8 
Range 2.6–63 μM 
Limit of detection (LOD)a 0.25 μM 
Limit of quantitation (LOQ)b 2.6 μM 
LOD was based on a signal-to-noise ratio of 3:1 
LOQ was defined as the lowest concentration for which acceptable results for precision (repeatability 
<20%) and accuracy (residual of <20%) were obtained. 
Table 2. Accuracy and precision for quantitative analysis of AIP-I. 
Theoretical 
concentration 
(μM) 
Measured 
concentrationa(μM) 
Residualsb(%) Repeatabilityc(%) Intermediate 
precisiond(%) 
2.6 2.2 16 3.4 37 
5.2 4.7 8.5 2.3 9.5 
10.4 9.8 5.2 3.8 3.3 
20.8 21.1 1.8 2.8 4.7 
31.2 32.3 3.5 3.0 5.2 
41.7 42.5 2.1 4.9 5.2 
52.1 53.1 1.9 1.9 4.7 
62.5 60.6 3.1 1.5 3.3 
a The measured concentration is an average of the back calculated concentration of AIP-I (in 
tryptic soy broth medium) obtained for three triplicate analyses conducted on three different 
days. bResiduals are calculated as follows: (measured concentration − theoretical 
concentration)/theoretical concentration × 100. cRepeatabilty is expressed as the % relative 
standard deviation for back calculated AIP-I concentrations determined by triplicate analyses 
conducted on a single day. d Intermediate precision is expressed as the % relative standard 
deviation of the three back-calculated AIP-I concentrations (each an average of triplicate 
measurements) determined on three separate days. 
3.3. Time-dependent AIP-I production and relationship between AIP production and virulence 
ofS. aureus strains 
The method described herein was applied to answer several biologically relevant questions 
regarding AIP-I production by S. aureus. First, our method allowed for instantaneous 
identification and quantification of AIP-I without tedious sample preparation. A study that 
focused on structure and activity of AIP-I estimated that the concentration of the thiolactone 
produced by S. aureus was in the approximate range of 10 μM [13]. However, the method used 
required a pre-concentration step with size exclusion filtration and solid phase extraction 
followed by two stages of bioassay-guided purification using reversed phase HPLC. Although 
the authors were able to obtain samples for activity determination, the method is not ideal to be 
adopted as a diagnostic tool to assess AIP production. The protracted time and expense required 
for sample preparation also make accurate quantitation challenging. The method described here 
confirms the concentration of AIP-I in spent media of S. aureus cultures by direct quantitative 
measurements. It was determined that AIP-I concentration varies depending on growth phase of 
a CA-MRSA USA300 strain, but is generally in the range of ~0.05 to 10 μM. Secondly, we 
investigated the production of AIP-I by CA-MRSA USA300 strain LAC over time ( Fig. 5). 
Under the conditions for this study, no AIP-I was detectable in the initial culture. The peptide 
was, however, detected at the 4 h time point, with a concentration of 1.1 ± 0.3 μM (expressed at 
mean ± standard error). This concentration should be interpreted as only approximate, being 
above the limit of detection (0.25 μM) but below the lower limit of the linear range of the 
calibration curve (2.3 μM). AIP-I levels then rose steadily to a maximum concentration of 
13 ± 2 μM at 16 h. After this time, the concentration leveled off until the last recorded time point 
at 21 h. 
 
Fig. 5. Production of AIP-I by strain LAC in TSB over time. Measurements were made of from 
triplicate culture flasks grown with shaking and aeration. Aliquots were removed at the indicated 
time points, measured for OD at 600 nm, filtered, and frozen for AIP-I analysis by LC–MS. 
Error bars indicate ± standard error (N = 3). 
Finally, literature has suggested that the activity of the agr quorum-sensing system can be 
correlated with the virulence potential of S. aureus strains [5], [6] and [7]. It was, therefore, of 
interest to evaluate the differences in AIP-I concentration produced by a series of strains 
representing different lineages and MRSA types, and to compare these concentrations to % 
rabbit red blood cell (RBC) lysis activity as a measure of virulence ( Fig. 6). Rabbit RBCs are 
hyper-susceptible to alpha-toxin lysis, and the function of the agrsystem directly correlates with 
alpha-toxin production levels [9] and [24]. For purposes of comparison, we have set CA-MRSA 
strain LAC at 100% RBC lysis and plotted other strains relative to this level. It is apparent from 
visual inspection of Fig. 6 that AIP-I levels vary significantly. CA-MRSA strains are known to 
be hypervirulent, due in part to elevated production of agr-regulated toxins and exo-
enzymes [4], [5] and [6]. Thus, it is not surprising that the CA-MRSA USA300 strains LAC and 
TCH1516 produced high levels of AIP-I (4.3 and 4.5 μM, respectively) that correlated with 
enhanced RBC lysis. Also as anticipated, hospital acquired methicillin-resistant S. aureus (HA-
MRSA) strain COL has comparatively weaker agr system function [5], reduced pathogenesis [4], 
and produced low levels of AIP-I and reduced lysis ( Fig. 6). As a control throughout this 
experiment, alpha-toxin levels were confirmed by immunoblot (data not shown). 
 
Fig. 6.  Comparison of AIP-I concentrations and rabbit red blood cell (RBC) lysis activity for 
different strains of S. aureus. Strains were grown in triplicate culture flasks to an OD600 of 2.0, 
and spent media was tested for AIP-I levels and RBC lysis. (A) AIP-I analysis by LC–MS of 
each strain. Error bars represent standard error (N = 3). (B) RBC lysis levels of each strain 
normalized to USA300 LAC (set to 100%). These lysis levels correlate with alpha-toxin 
production, which was confirmed through immunoblot (data not shown). Error bars represent 
standard error (N = 3). 
To further evaluate the relationship between AIP-I production and virulence, we extended the 
AIP-I analysis to other agr type I strains. We chose strains FRI1169, a known toxic shock toxin 
producer [18]; HG001, an engineered laboratory strain [16]; and four clonal complex 45 (CC45) 
strains. These strains were chose for their divergent backgrounds to gain insight on the generality 
of the UHPLC method application for S. aureus. Strain FRI1169 produced the highest levels of 
AIP-I (4.9 μM), but only triggered a moderate level of RBC lysis (49% of USA300 LAC). In 
contrast, HG001 had a similar ability to induce lysis but produced low levels of AIP-I (0.8 μM). 
Considerable variation was also observed in the CC45 strains. While strain AH1889 produced 
moderate levels of AIP-I and RBC lysis, other CC45 strains AH1886 and AH1887 produced low 
levels of AIP-I but retained high RBC lysis. These outliers, combined with the relatively low 
number of strains evaluated, meant that there was no significant statistical correlation between 
AIP-I production and % RBC lysis (Pearson correlation of 0.23, p = 0.53). However, it should be 
noted that only one time point was chosen for these studies, and agr system dynamics will vary 
over time across S. aureus strains. Taken together, the levels of AIP-I show striking consistency 
with the reported virulence properties of some strains, such as CA-MRSA USA300 strains, but 
our additional studies demonstrate that quantifying AIP should not be considered in isolation as 
the only metric of S. aureus pathogenic potential. 
4. Conclusions 
This study demonstrates the power of UHPLC coupled to high resolving power mass 
spectrometry for quantifying biologically relevant analytes in challenging matrices. The UHPLC 
enabled shorter run times than were possible with other methods. Furthermore, quantitative 
analysis of an autoinducing peptide was possible directly from complex culture media. The 
quantitative method facilitated comparisons of the absolute levels of AIP-I produced by S. 
aureus strains with varying virulence. It was observed that the highest AIP-I levels were 
produced by the CA-MRSA USA300 strains and low AIP-I levels are produced by HA-MRSA, 
both observations that are supported by pathogenic assessments of these strains. Thus, 
measurements of AIP-I levels may have value as an indicator of S. aureus virulence that could be 
used in conjunction with more traditional pathogenesis assessments. Furthermore, this new 
method for quantifying AIP-I could be applied to other classes of AIP structures to assess signal 
production across diverse Gram-positive bacterial pathogens. 
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